No Data
No Data
Wolfe Research Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Announces Target Price $518
Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $518 From $576, Maintains Outperform Rating
What Analysts Are Saying About Vertex Pharmaceuticals Stock
Vertex Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley
Vertex Pharmaceuticals Analyst Ratings
Morgan Stanley Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating, Raises Target Price to $474